Fund HoldingsPropel Bio Management, LLC

Total Portfolio Value
$191.09M
Total Bought
$49.51M
Total Sold
$42.35M
Net Transaction
+$7.16M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
ACHIEVE LIFE SCIENCES INC3,786,4254,034,018+247,59311,36926,34213.79%+14,973
CORCEPT THERAPEUTICS INC(CORT)147,828136,499-11,3296,02211,8696.21%+5,847
ARTIVA BIOTHERAPEUTICS IN(ARTV)146,369696,436+550,0679506,7553.54%+5,806
IMMUNIC INC(IMUX)0325,022+325,02204,9962.61%+4,996
MILESTONE PHARMACEUTICALS(MIST)4,118,3217,429,590+3,311,2695,0829,9565.21%+4,874
COMPASS PATHWAYS PLC(CMPS)742,049573,086-168,9634,1188,1094.24%+3,991
PALISADE BIO INC(PALI)1,115,0002,582,388+1,467,3881,9975,3972.82%+3,400
AQUESTIVE THERAPEUTICS IN710,9881,442,397+731,4092,9516,0003.14%+3,050
KYVERNA THERAPEUTICS INC(KYTX)644,421883,198+238,7775,5867,8694.12%+2,284
SCYNEXIS INC0543,478+543,47802,2121.16%+2,212
SILENCE THERAPEUTICS PLC(SLN)0191,733+191,73302,1051.10%+2,105
PHATHOM PHARMACEUTICALS I(PHAT)841,2721,050,358+209,0869,35411,3965.96%+2,042
DELCATH SYSTEMS INC(DCTH)979,698871,460-108,2389,15910,9725.74%+1,812
ZEVRA THERAPEUTICS INC(ZVRA)282,418253,544-28,8742,6413,6361.90%+995
SAGIMET BIOSCIENCES INC-A(SGMT)0125,878+125,87809730.51%+973
OVID THERAPEUTICS INC(OVID)921,4571,115,538+194,0812,0383,0011.57%+963
INVENTIVA SA - ADR(IVA)724,6781,281,212+556,5343,9954,8432.53%+848
PLAINS GP HOLDINGS LP-CL(PAGP)1,272,3601,272,360030,18030,88016.16%+700
SAB BIOTHERAPEUTICS INC(SABS)1,012,7901,076,578+63,7883,8864,1992.20%+312
OCULAR THERAPEUTIX INC(OCUL)382,375357,966-24,4093,2263,5151.84%+289
ABEONA THERAPEUTICS INC(ABEO)1,329,899983,070-346,8296,0086,0753.18%+67
ORCHESTRA BIOMED HOLDINGS(OBIO)896,701896,70103,8313,8692.02%+39
MAZE THERAPEUTICS INC(MAZE)43,79843,79801,3071,3070.68%-0
EYEPOINT INC(EYPT)215,825191,745-24,0802,7892,7421.43%-47
SATELLOS BIOSCIENCE INC(MSLE)10,1450-10,145570-57
LEONABIO INC(LONA)149,279149,27901,4961,3720.72%-124
CORVUS PHARMACEUTICALS INC(CRVS)85,79170,380-15,4111,2511,0510.55%-200
4D MOLECULAR THERAPEUTICS IN380,420252,654-127,7663,5813,3601.76%-221
CELLDEX THERAPEUTICS INC(CLDX)131,364103,695-27,6694,1353,8582.02%-277
CONNECT BIOPHARMA HLDGS LTD(CNTB)209,4930-209,4935540-554
UPSTREAM BIO INC(UPB)341,779350,389+8,6103,1002,4251.27%-675
ALDEYRA THERAPEUTICS INC(ALDX)730,6060-730,6061,2350-1,235
EVOMMUNE INC(EVMN)55,6640-55,6641,2800-1,280
NUVATION BIO INC(NUVB)329,2960-329,2961,4130-1,413
UNIQURE NV(QURE)104,7720-104,7721,7130-1,713
KALARIS THERAPEUTICS INC(KLRS)295,7710-295,7711,7210-1,721
COHERUS ONCOLOGY INC(CHRS)1,420,5500-1,420,5502,4130-2,413
IMMUNIC INC(IMUX)2,344,7790-2,344,7792,6200-2,620
TREVI THERAPEUTICS INC(TRVI)223,8020-223,8022,6470-2,647
OCULIS HOLDING AG(OCS)122,2230-122,2233,2790-3,279
VIRIDIAN THERAPEUTICS INC(VRDN)210,1630-210,1634,0880-4,088
VOR BIOPHARMA INC(VOR)314,5430-314,5435,5870-5,587
Page 1 of 1
Propel Bio Management, LLC — 13F Holdings — Q2 2026 | TickerTrail